Yahoo Finance Insider Sell: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)
Steven Chapman, CEO and President of Natera Inc (NASDAQ:NTRA), has sold 6,816 shares of the company on April 15, 2024, according to a recent SEC Filing. The transaction was executed at an average price of $93.13 per share, resulting in a total value of $634,720.48.Natera Inc is a pioneer in the field of genetic testing and diagnostics, offering a range of services including prenatal testing, cancer screening, and organ health monitoring. The company leverages advanced technology to provide accurate and actionable insights that can guide patient care and inform clinical decisions.Over the past year, the insider has sold a total of 190,425 shares of Natera Inc and has not made any purchases of the stock. The recent sale by the insider is part of a trend observed over the last year, where there have been no insider buys and 75 insider sells for the company.
On the valuation front, Natera Inc's shares were trading at $93.13 on the day of the insider's sale, giving the company a market capitalization of $10.91 billion. The stock's price-to-GF-Value ratio stands at 1.43, indicating that Natera Inc is significantly overvalued when compared to the GuruFocus Value of $65.07.
The GF Value is determined by considering historical trading multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on the company's historical returns and growth, and future business performance estimates from Morningstar analysts.The insider's recent transaction may provide investors with an insight into the insider's perspective on the stock's current valuation and future prospects. However, it is important for investors to consider a wide range of factors, including market conditions and individual investment goals, when making investment decisions.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
